Researchers identify pitfall in popular prostate cancer PET imaging method

Awareness of the potential to misinterpret PSMA PET results can increase diagnostic accuracy and more accurately guide therapy

Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging has become a popular method for determining the stage of a patient's prostate cancer. However, researchers have identified a major pitfall in this imaging technique and are cautioning medical professionals to be aware of the potential for misdiagnosis when relying solely on PSMA PET. Read more.